Invention Application
- Patent Title: USE OF PRIDOPIDINE FOR THE TREATMENT OF FRAGILE X SYNDROME
-
Application No.: US17588403Application Date: 2022-01-31
-
Publication No.: US20220202798A1Publication Date: 2022-06-30
- Inventor: Michael HAYDEN , Mahmoud Abdulhossein POULADI
- Applicant: PRILENIA NEUROTHERAPEUTICS LTD. , NATIONAL UNIVERSITY OF SINGAPORE , AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
- Applicant Address: IL Herzliya; SG Singapore; SG SINGAPORE
- Assignee: PRILENIA NEUROTHERAPEUTICS LTD.,NATIONAL UNIVERSITY OF SINGAPORE,AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
- Current Assignee: PRILENIA NEUROTHERAPEUTICS LTD.,NATIONAL UNIVERSITY OF SINGAPORE,AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
- Current Assignee Address: IL Herzliya; SG Singapore; SG SINGAPORE
- Main IPC: A61K31/451
- IPC: A61K31/451 ; A61P43/00 ; A61K9/00
Abstract:
The invention provides a method of treating a subject afflicted with fragile X syndrome (FXS) or a FXS related disorder, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.
Information query
IPC分类:
